These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6930879)

  • 1. Longitudinal study of cardiac function in thalassemia major.
    Ehlers KH; Levin AR; Markenson AL; Marcus JR; Klein AA; Hilgartner MW; Engle MA
    Ann N Y Acad Sci; 1980; 344():397-404. PubMed ID: 6930879
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of subcutaneous deferoxamine on the cardiac profile of thalassemia major: a five-year study.
    Giardina PJ; Ehlers KH; Engle MA; Grady RW; Hilgartner MW
    Ann N Y Acad Sci; 1985; 445():282-92. PubMed ID: 3860132
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of cardiac function in patients with thalassemia major.
    Nienhuis AW; Griffith P; Strawczynski H; Henry W; Borer J; Leon M; Anderson WF
    Ann N Y Acad Sci; 1980; 344():384-96. PubMed ID: 6930878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heart in thalassemia: a comprehensive review.
    Sahasakul Y; Chithiraphan S
    J Med Assoc Thai; 1985 Oct; 68(10):517-27. PubMed ID: 3908610
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology and treatment of iron overload in thalassemia patients in tropical countries.
    Marx JJ
    Adv Exp Med Biol; 2003; 531():57-68. PubMed ID: 12916781
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalassemic cardiopathy: current concepts.
    Mohan JC; Reddy KS
    Indian J Pediatr; 1984; 51(411):383-6. PubMed ID: 6396229
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload.
    Leon MB; Borer JS; Bacharach SL; Green MV; Benz EJ; Griffith P; Nienhuis AW
    N Engl J Med; 1979 Nov; 301(21):1143-8. PubMed ID: 492276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the diastolic phase of the left ventricle, using the apex cardiogram, in patients with thalassemia major].
    Roncon L; Sartorelli L; Fiorencis R; Canova C; Zanazzi G; Cichella E; Pizzardo A; Zonzin P
    G Clin Med; 1983 Nov; 64(11):420-7. PubMed ID: 6667797
    [No Abstract]   [Full Text] [Related]  

  • 10. The management of thalassemia major.
    Pearson HA; O'Brien RT
    Semin Hematol; 1975 Jul; 12(3):255-65. PubMed ID: 1079633
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac complications in homozygous beta-thalassemia.
    Wonke B; Hoffbrand AV; Aldouri MA; Ward SE
    Prog Clin Biol Res; 1989; 309():51-6. PubMed ID: 2780750
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac abnormalities in the thalassaemia syndromes.
    Yee H; Mra R; Nyunt KM
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):414-21. PubMed ID: 6523177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrocardiographic and radiologic evaluation in cardiac involvement in patients with beta-thalassemia major].
    Lo Jacono F; Agnello D; Malizia R; Maltese I; Marasa' R
    Pediatria (Napoli); 1980 Sep; 88(3):385-93. PubMed ID: 7220158
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiac dysfunction in children with thalassemia major].
    Angelika L; Graf N; Hoffmann W
    Klin Padiatr; 1988; 200(2):102-7. PubMed ID: 3386182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac tamponade in thalassemia after chemotherapy for BMT.
    Baronciani D; Angelucci E; Mariotti E; Galimberti M; Polchi P; Giardini C; Baldassarri M; Martinelli F; Lucarelli G
    Bone Marrow Transplant; 1993; 12 Suppl 1():91-2. PubMed ID: 8374575
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbohydrate homeostasis and pancreatic islet cell funtion in thalassemia.
    Lassman MN; Genel M; Wise JK; Hendler R; Felig P
    Ann Intern Med; 1974 Jan; 80(1):65-9. PubMed ID: 4589513
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical management of beta-thalassemia.
    Lerner N
    Prog Clin Biol Res; 1989; 309():13-22. PubMed ID: 2780747
    [No Abstract]   [Full Text] [Related]  

  • 18. Histochemical studies of the myocardium and conduction system in acquired iron-storage disease.
    Schellhammer PF; Engle MA; Hagstrom JW
    Circulation; 1967 Apr; 35(4):631-7. PubMed ID: 6024007
    [No Abstract]   [Full Text] [Related]  

  • 19. [The endocrine complications in thalassemia major].
    Anastasi S; Caruso V; Magnano C; Leocata A
    Pediatr Med Chir; 1991; 13(1):63-5. PubMed ID: 2052458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of hospital admission in children and adults with transfusion-dependent thalassemia in Sardinia, 2000-2015.
    Origa R; Anni F; Mereu L; Follesa I; Campus S; Dessì C; Foschini ML; Leoni G; Moi P; Morittu M; Orecchia V; Perra M; Zappu A; Podda RA
    Ann Hematol; 2017 Jun; 96(6):1041-1042. PubMed ID: 28280993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.